Tristel Share News (TSTL)

Tristel Information

Buy TSTL Shares
Add TSTL to Watchlist
Add TSTL to Alert

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 417.50

Bid: 410.00

Ask: 425.00

Change: -2.50 (-0.60%)

Spread: 15.00 (3.659%)

Open: 420.00

High: 420.00

Low: 417.50

Prev. Close: 420.00

Last checked at -

Tristel annual revenue and profit up thanks to robust demand

Tue, 25th Jul 2023 10:56

(Alliance News) - Tristel PLC on Tuesday said it expects to see annual revenue and profit ahead of expectations, driven by robust demand.

Shares in the Cambridgeshire-based maker of infection prevention products were up 4.9% to 372.50 pence each in London on Tuesday morning.

Tristel said that demand for its infection prevention products for medical device decontamination and for the sporicidal disinfection of surfaces continues to be "very robust across all key geographical markets."

As a result, revenue for the year ended June 30 was up 16% to GBP36.0 million from GBP31.1 million the year earlier. It said that this is ahead of consensus forecasts and above the company's long-term target for revenue growth.

Adjusted pretax profit will be slightly ahead of consensus forecasts of GBP6 million. This is also significantly ahead of financial 2022's pretax profit of GBP1.5 million.

Tristel noted that it continues to be debt free and cash generative. Cash balances on June 30 were GBP9.5 million, up from GBP8.9 million year-on-year.

Further, the company said that 17 million disinfection events took place during the financial year using Tristel's chemistry, up 8.2% from 15.7 million the previous year. This is also 42% higher than in the year before Covid-19 temporarily disrupted Tristel's normal operational performance.

Chief Executive Paul Swinney said: "I am delighted to confirm to shareholders that the business continues to deliver a strong trading performance and growth ahead of both analyst expectations and our own growth targets.

"Looking forward to the years ahead, I am confident that Tristel will truly become a leading global player in the infection prevention industry. We now have access to the world's largest ultrasound market for our high-level medical device decontamination products and we have an exciting pipeline of new product innovations supported by a strong balance sheet."

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

9 Sep 2010 14:44

London afternoon: ARM gives Footsie a hand

Mining stocks continue to drive the market's advance, despite metal prices falling back as concerns grow about the Chinese authorities' determination to cool off the economy, with the latest report from the People's Republic suggesting that the government is set to introduce measures to curb propert

28 Jun 2010 16:33

Non-exec's firm cashes in at Lancashire

Lancashire Holdings non-executive director Barry Volpert is chief executive of private equity firm Crestview, which has raised more than £4.7m from the sale of shares in the property, aviation and marine insurer. The share prices of the five separate disposals varied from 497p to just over 500p. C

8 Mar 2010 09:00

Tristel profits climb after acquisition

Disinfectant supplier Tristel posted a rise in turnover and profits in the six months to December 31 as it proceeded with the integration of a portfolio of products it acquired from Medichem. Pre-tax profits climbed to £656,000 from £469,000 over the same period the previous year as revenues climbe

4 Dec 2009 16:26

Ultra boss sells

Ultra Electronics chief executive Douglas Caster has generated £5.85m from the sale of just over two-fifths of his shareholding in the defence electronics supplier. He states in the announcement that the sale was for "family and tax planning reasons". Caster has also transferred his remaining 63

9 Nov 2009 11:43

Small caps round-up: Nautical Petroleum, ThirdForce, Allied Gold...

Oil group Nautical Petroleum reported 'significant progress' in its asset portfolio in the year to June 30 and said it expects its assets to rise in value once they move into the execution stage. Pre-tax losses for the year totalled £6.63m, compared with £4.52m the previous year. Shares in e-learn

12 Oct 2009 15:49

Comment: Tristel looks to clean up overseas

Tristel chief executive Paul Swinney described the infection and contamination control company's results as 'good, if not spectacular' but his modesty contrasts with his excitement about the prospect of overseas expansion. In the year to June 30, Tristel, whose products are used to combat infection

12 Oct 2009 07:17

Tristel ups divi as profits climb

The continuing struggle to keep infections such as Clostridium difficile out of hospitals helped disinfectant supplier Tristel post a rise in turnover and profits in the year to June 30. Tristel, whose products are based on chlorine dioxide chemistry, said revenues climbed to £6.8m from £6m over th

3 Jul 2009 17:08

Tristel chairman sells

Francisco Soler, non-executive chairman of Tristel, sold £315,680 worth of shares in the disinfectant supplier to satisfy institutional demand following the group's oversubscribed placing. Soler disposed of 769,951 shares in Tristel at 41p each as the group raised £1m to part finance the purchase

3 Jul 2009 07:47

Tristel gets £1m towards portfolio purchase

Disinfectant supplier Tristel has raised £1m to part finance the purchase of a portfolio of infection control products for between £2.15m and £2.4m. It has placed 2.7m shares at 41p each, which will help buy intellectual property and manufacturing rights from Medichem International. The placing was

Latest Share Chat

Tristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tristel annual revenue and profit up thanks to robust demand

Login to your account

Quickpicks are a member only feature

Login to your account